US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

35.69

+1.343.90%

Post-market: 35.690.00000.00%19:49 EDT

Volume:2.69M

Turnover:95.67M

Market Cap:4.21B

PE:12.90

High:35.90

Open:34.76

Low:34.47

Close:34.35

52wk High:42.81

52wk Low:22.22

Shares:118.00M

Float Shares:116.45M

Volume Ratio:1.27

T/O Rate:2.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.77

EPS(LYR):1.64

ROE:12.20%

ROA:26.40%

PB:-20.25

PE(LYR):21.76

Loading ...

Overview Company News Filings

Indivior Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Switzerland's Crispr Therapeutics Q2 Casgevy Revenue Jumps 151%, Net Loss Narrows on FDA Approval for Expansion

Crinetics Q2 Revenue Jumps on Palsonify Launch, Withdraws Guidance

Germany's Fresenius Medical Q2 Revenue Beats; 2026 Outlook Reaffirmed

U.S. Stocks on the MOVE -Visa, Bowhead Specialty, Micron

Indivior and Supernus announce tax-free merger of equals

Supernus, Indivior Merge to Strengthen Neuroscience Drug Portfolio

TG Therapeutics Q2 Product Revenue Rises 70% on Briumvi Sales

Indivior Announces Merger Agreement to Acquire Supernus

Indivior Pharmaceuticals, Supernus Pharmaceuticals to Combine in All-Stock Merger

MT Newswires Live

Indivior Pharmaceuticals Inc: Supernus Must Pay Co Termination Fee of $101 Mln if the Merger Agreement is Terminated Under Certain Circumstances

THOMSON REUTERS

Indivior Pharmaceuticals Beats Q2 Revenue on Sublocade Growth, Raises FY Guidance

GUIDANCE: (INDV) Indivior Expects 2026 Net Revenue Range $1.30B - $1.37B, vs. FactSet Est of $1.26B

MT Newswires Live

Supernus Q2 FY26 Net Loss Widens to $58.4 Million; Revenue Rises 32% to $219.1 Million

Indivior Q2 Adj. EPS $1.15 Beats $0.87 Estimate, Sales $343.000M Beat $307.550M Estimate

Benzinga Earnings

Supernus Pharmaceuticals Shares Rise 5.3% Premarket After Co to Merge with Indivior Pharmaceuticals

THOMSON REUTERS

Indivior Q2 FY26 GAAP Net Income Rises to $122 Million; Revenue Increases 14% to $343 Million YoY

Indivior Pharmaceuticals Q2 Revenue USD 343 Million Vs. IBES Estimate USD 307.6 Million

Indivior Pharmaceuticals Outlook FY Revenue USD 1,295-1,365 Million

THOMSON REUTERS

Press Release: Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/INDV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"INDV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDV\",,,,,undefined,":{"symbol":"INDV","market":"US","secType":"STK","nameCN":"INDIVIOR PLC","latestPrice":35.69,"timestamp":1789675200000,"preClose":34.35,"halted":0,"volume":2690472,"hourTrading":{"tag":"盘后","latestPrice":35.69,"preClose":35.69,"latestTime":"19:49 EDT","volume":1052918,"amount":37578649.285,"timestamp":1789688970204,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03901018922852973,"floatShares":116454522,"shares":118000000,"eps":2.766067,"marketStatus":"Closed","change":1.34,"latestTime":"09-17 16:00:00 EDT","open":34.76,"high":35.9,"low":34.47,"amount":95671268.70393601,"amplitude":0.04163,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.766067,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":34.35,"preHourTrading":{"tag":"盘前","latestPrice":34.74,"preClose":34.35,"latestTime":"09:29 EDT","volume":9631,"amount":339982.58266,"timestamp":1789651799999,"change":0.39,"changeRate":0.011354,"amplitude":0.067307},"postHourTrading":{"tag":"盘后","latestPrice":35.69,"preClose":35.69,"latestTime":"19:49 EDT","volume":1052918,"amount":37578649.285,"timestamp":1789688970204,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.267572,"impliedVol":0.2953,"impliedVolPercentile":0.0558},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDV\",,,,,undefined,":{"symbol":"INDV","floatShares":116454522,"roa":"26.40%","roe":"12.20%","lyrEps":1.64,"volumeRatio":1.267572,"shares":118000000,"dividePrice":0,"high":35.9,"amplitude":0.04163,"preClose":34.35,"low":34.47,"week52Low":22.22,"pbRate":"-20.25","psRate":"3.16","week52High":42.81,"institutionHeld":0,"latestPrice":35.69,"eps":2.766067,"divideRate":0,"volume":2690472,"delay":0,"ttmEps":2.766067,"open":34.76,"prevYearClose":35.88,"prevWeekClose":34.49,"prevMonthClose":34.93,"prevQuarterClose":41.03,"fiveDayClose":34.51,"twentyDayClose":39.04,"sixtyDayClose":39.96,"dividendPayoutRate":1.9539525374644688,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.02676056338028169},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INDV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"INDV","fiscalQuarterEnding":"2026/06","expectedEps":0.97,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":1.15},{"market":"US","date":"2026-04-30","symbol":"INDV","fiscalQuarterEnding":"2026/03","expectedEps":0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":0.96},{"market":"US","date":"2026-02-26","symbol":"INDV","fiscalQuarterEnding":"2025/12","expectedEps":0.65,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":0.82},{"market":"US","date":"2026-01-26","symbol":"INDV","reason":null,"defaultRemindTime":1769437800000,"announcedDate":"2026-01-23","type":"delisting","dateTimestamp":1769403600000},{"market":"US","date":"2025-10-30","symbol":"INDV","fiscalQuarterEnding":"2025/09","expectedEps":0.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"pre","actualEps":0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INDV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INDV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1781841600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INDV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INDV","date":"2026-09-16","current":12.902797,"percent":0.41896,"low":-539.080629,"twenty":-24.967722,"median":17.954474,"eighty":56.235876,"high":1520.868351,"avg":86.844861,"sd":411.769381,"marketCap":4038427068},"quantilePoints":[{"date":"2024-01-05","current":-8.731325,"twenty":-8.731325,"median":-8.731325,"eighty":-8.731325,"marketCap":2051861355.61},{"date":"2024-01-12","current":-9.061129,"twenty":-8.930914,"median":-8.915467,"eighty":-8.872434,"marketCap":2129365213.58},{"date":"2024-01-19","current":-9.036937,"twenty":-9.037083,"median":-8.926675,"eighty":-8.867596,"marketCap":2123680078.16},{"date":"2024-01-26","current":-10.054308,"twenty":-9.927259,"median":-9.036937,"eighty":-8.901284,"marketCap":2362762158.39},{"date":"2024-02-02","current":-10.004449,"twenty":-10.01442,"median":-9.223686,"eighty":-8.919649,"marketCap":2351045521.54},{"date":"2024-02-09","current":-10.098427,"twenty":-10.051065,"median":-9.895497,"eighty":-8.929219,"marketCap":2373130321.56},{"date":"2024-02-16","current":-10.175342,"twenty":-10.179852,"median":-9.943541,"eighty":-8.977536,"marketCap":2391205561.35},{"date":"2024-02-23","current":1442.16344,"twenty":-10.183288,"median":-9.929623,"eighty":-8.965881,"marketCap":2884326878.5},{"date":"2024-03-01","current":1520.868351,"twenty":-10.175772,"median":-9.860171,"eighty":-8.862758,"marketCap":3041736702.67},{"date":"2024-03-08","current":1456.331845,"twenty":-10.129193,"median":-9.478841,"eighty":1456.594636,"marketCap":2912663689.17},{"date":"2024-03-15","current":1406.519641,"twenty":-10.071956,"median":-9.037667,"eighty":1456.594636,"marketCap":2813039280.38},{"date":"2024-03-22","current":1416.408463,"twenty":-10.051876,"median":-8.960053,"eighty":1447.830802,"marketCap":2832816924.48},{"date":"2024-03-28","current":1455.260447,"twenty":-10.040734,"median":-8.915467,"eighty":1455.903286,"marketCap":2910520894.48},{"date":"2024-04-05","current":1458.075233,"twenty":-10.017652,"median":-8.848243,"eighty":1457.639065,"marketCap":2916150468.02},{"date":"2024-04-12","current":1329.065563,"twenty":-9.996443,"median":1356.65224,"eighty":1456.726031,"marketCap":2658131124.79},{"date":"2024-04-19","current":1279.103138,"twenty":-9.969287,"median":1309.349865,"eighty":1455.903286,"marketCap":2558206276.88},{"date":"2024-04-26","current":476.533403,"twenty":-9.944147,"median":1284.511395,"eighty":1452.111517,"marketCap":2382667015.68},{"date":"2024-05-03","current":485.430033,"twenty":-9.931801,"median":1275.015426,"eighty":1446.43078,"marketCap":2427150166.81},{"date":"2024-05-10","current":484.77744,"twenty":-9.909437,"median":493.219646,"eighty":1443.862237,"marketCap":2423887197.01},{"date":"2024-05-17","current":457.733314,"twenty":-9.881367,"median":488.116405,"eighty":1441.351048,"marketCap":2288666574.17},{"date":"2024-05-24","current":465.20437,"twenty":-9.858941,"median":485.295631,"eighty":1439.871356,"marketCap":2326021847.95},{"date":"2024-05-31","current":496.261466,"twenty":-9.799964,"median":486.27573,"eighty":1436.258175,"marketCap":2481307333.36},{"date":"2024-06-07","current":439.995107,"twenty":-9.5344,"median":485.430033,"eighty":1423.367779,"marketCap":2199975534.13},{"date":"2024-06-14","current":451.615042,"twenty":-9.386243,"median":484.77744,"eighty":1423.350602,"marketCap":2258075214.65},{"date":"2024-06-21","current":447.135681,"twenty":-9.126152,"median":483.175553,"eighty":1421.904534,"marketCap":2235678403.11},{"date":"2024-06-28","current":420.240739,"twenty":-9.056437,"median":482.881297,"eighty":1420.903799,"marketCap":2101203699.91},{"date":"2024-07-05","current":399.169394,"twenty":-9.037667,"median":478.317711,"eighty":1418.346927,"marketCap":1995846972.62},{"date":"2024-07-12","current":281.71779,"twenty":-9.036937,"median":474.886858,"eighty":1416.476807,"marketCap":1408588947.59},{"date":"2024-07-15","current":269.124484,"twenty":-9.027388,"median":474.396895,"eighty":1416.463138,"marketCap":1345622420.31},{"date":"2024-08-02","current":-12.681184,"twenty":-9.037375,"median":474.162636,"eighty":1416.449469,"marketCap":1788046959.52},{"date":"2024-08-09","current":-11.831658,"twenty":-9.742833,"median":463.001654,"eighty":1415.475285,"marketCap":1668263747.87},{"date":"2024-08-16","current":-11.531835,"twenty":-9.931801,"median":456.721797,"eighty":1411.053167,"marketCap":1625988694.51},{"date":"2024-08-23","current":-11.359567,"twenty":-10.017652,"median":455.124507,"eighty":1403.016644,"marketCap":1601698904.31},{"date":"2024-08-30","current":-11.517339,"twenty":-10.144576,"median":449.847335,"eighty":1394.819348,"marketCap":1623944812.52},{"date":"2024-09-06","current":-9.739044,"twenty":-10.190159,"median":447.535315,"eighty":1390.076063,"marketCap":1373205236.08},{"date":"2024-09-13","current":-9.093341,"twenty":-10.176202,"median":437.901092,"eighty":1388.200752,"marketCap":1282161095.35},{"date":"2024-09-20","current":-8.695405,"twenty":-10.159959,"median":436.792984,"eighty":1385.619667,"marketCap":1226052087.81},{"date":"2024-09-27","current":-9.187795,"twenty":-10.089603,"median":420.240739,"eighty":1373.204246,"marketCap":1295479177.06},{"date":"2024-10-04","current":-9.452398,"twenty":-10.053497,"median":411.279432,"eighty":1328.888735,"marketCap":1332788098.86},{"date":"2024-10-11","current":-6.894174,"twenty":-10.045494,"median":397.767615,"eighty":1324.41511,"marketCap":972078462.1},{"date":"2024-10-18","current":-7.729502,"twenty":-10.022053,"median":275.421137,"eighty":1306.911197,"marketCap":1089859827.76},{"date":"2024-10-25","current":-387.254131,"twenty":-10.022053,"median":258.931158,"eighty":1295.294828,"marketCap":1161762392.56},{"date":"2024-10-31","current":-376.128091,"twenty":-10.098427,"median":-6.913465,"eighty":1287.84805,"marketCap":1128384273.39},{"date":"2024-11-08","current":-434.650258,"twenty":-10.197534,"median":-7.218189,"eighty":1281.174739,"marketCap":1303950773.11},{"date":"2024-11-15","current":-417.553766,"twenty":-10.357169,"median":-7.68996,"eighty":1279.103138,"marketCap":1252661295.74},{"date":"2024-11-22","current":-455.401138,"twenty":-11.279742,"median":-7.770979,"eighty":1275.015426,"marketCap":1366203413.46},{"date":"2024-11-29","current":-475.483527,"twenty":-11.472459,"median":-8.119915,"eighty":1262.088941,"marketCap":1426450581.27},{"date":"2024-12-06","current":-462.637374,"twenty":-11.520238,"median":-8.577538,"eighty":649.987226,"marketCap":1387912124.34},{"date":"2024-12-13","current":-484.970807,"twenty":-11.624468,"median":-8.706737,"eighty":497.452148,"marketCap":1454912419.5},{"date":"2024-12-20","current":-483.00699,"twenty":-11.880785,"median":-8.81707,"eighty":496.483725,"marketCap":1449020970.4},{"date":"2024-12-27","current":-524.024438,"twenty":-12.457859,"median":-8.855646,"eighty":495.297532,"marketCap":1572073311.64},{"date":"2025-01-03","current":-526.020236,"twenty":-230.749328,"median":-8.892068,"eighty":493.586593,"marketCap":1578060706.99},{"date":"2025-01-10","current":-497.27008,"twenty":-384.916258,"median":-8.907363,"eighty":491.400602,"marketCap":1491810238.16},{"date":"2025-01-17","current":-486.412641,"twenty":-393.098632,"median":-8.915467,"eighty":488.91137,"marketCap":1459237922.85},{"date":"2025-01-24","current":-489.294402,"twenty":-425.635451,"median":-8.960053,"eighty":488.290719,"marketCap":1467883205.21},{"date":"2025-01-31","current":-495.059612,"twenty":-434.650258,"median":-9.004691,"eighty":488.174377,"marketCap":1485178837.55},{"date":"2025-02-07","current":-398.440394,"twenty":-438.198605,"median":-9.035763,"eighty":488.116405,"marketCap":1195321181.39},{"date":"2025-02-14","current":-410.047551,"twenty":-437.752568,"median":-9.061129,"eighty":487.121427,"marketCap":1230142653.13},{"date":"2025-02-21","current":-22.522233,"twenty":-439.344773,"median":-9.095438,"eighty":485.768312,"marketCap":1081067217.57},{"date":"2025-02-28","current":-22.859537,"twenty":-437.841775,"median":-9.294936,"eighty":485.214989,"marketCap":1097257759.94},{"date":"2025-03-07","current":-24.283428,"twenty":-437.023459,"median":-9.444366,"eighty":484.854198,"marketCap":1165604557.36},{"date":"2025-03-14","current":605.149026,"twenty":-435.088443,"median":-9.294936,"eighty":488.127999,"marketCap":1210298050.41},{"date":"2025-03-21","current":-25.271265,"twenty":-433.037368,"median":-9.386243,"eighty":488.197645,"marketCap":1213020698.87},{"date":"2025-03-28","current":-24.738754,"twenty":-430.777799,"median":-9.448382,"eighty":488.127999,"marketCap":1187460219.29},{"date":"2025-04-04","current":-24.352592,"twenty":-427.288281,"median":-9.739044,"eighty":487.320423,"marketCap":1168924445.9},{"date":"2025-04-11","current":-23.146184,"twenty":-425.814745,"median":-9.877834,"eighty":485.768312,"marketCap":1111016863.05},{"date":"2025-04-17","current":-23.722243,"twenty":-421.727469,"median":-9.929623,"eighty":485.26875,"marketCap":1138667669.28},{"date":"2025-04-25","current":-21.827382,"twenty":-418.181119,"median":-9.984433,"eighty":484.930955,"marketCap":1353297690.88},{"date":"2025-05-02","current":-23.745782,"twenty":-414.153201,"median":-10.038354,"eighty":483.882407,"marketCap":1472238458.47},{"date":"2025-05-09","current":-22.159707,"twenty":-410.782993,"median":-10.098427,"eighty":483.219619,"marketCap":1373901817.96},{"date":"2025-05-16","current":-22.569779,"twenty":-408.327019,"median":-10.185005,"eighty":482.998999,"marketCap":1399326293.84},{"date":"2025-05-23","current":-22.3193,"twenty":-401.936236,"median":-10.311545,"eighty":482.806461,"marketCap":1383796581.45},{"date":"2025-05-30","current":-25.63971,"twenty":-396.501678,"median":-10.3517,"eighty":480.981026,"marketCap":1589662006.96},{"date":"2025-06-06","current":-27.767026,"twenty":-393.177531,"median":-11.138759,"eighty":477.603988,"marketCap":1721555638.78},{"date":"2025-06-13","current":-28.024212,"twenty":-392.348167,"median":-11.279742,"eighty":476.07077,"marketCap":1737501138.51},{"date":"2025-06-20","current":-28.284472,"twenty":-391.855975,"median":-11.446173,"eighty":475.180835,"marketCap":1753637267.93},{"date":"2025-06-27","current":-27.245913,"twenty":-390.345823,"median":-11.490318,"eighty":474.303192,"marketCap":1689246563.77},{"date":"2025-07-03","current":-31.054113,"twenty":-387.254131,"median":-11.508717,"eighty":473.928378,"marketCap":1925355009.01},{"date":"2025-07-11","current":-31.171056,"twenty":-387.002934,"median":-11.55631,"eighty":465.20437,"marketCap":1932605447.05},{"date":"2025-07-18","current":-32.333828,"twenty":-385.010735,"median":-11.628362,"eighty":463.001654,"marketCap":2004697356.56},{"date":"2025-07-25","current":-33.722781,"twenty":-384.538351,"median":-11.705533,"eighty":457.733314,"marketCap":2090812381.22},{"date":"2025-08-01","current":47.55378,"twenty":-383.933492,"median":-11.954476,"eighty":457.459813,"marketCap":2520350364},{"date":"2025-08-08","current":51.908953,"twenty":-383.123313,"median":-11.661073,"eighty":455.983781,"marketCap":2751174531},{"date":"2025-08-15","current":54.545599,"twenty":-376.128091,"median":-11.608831,"eighty":455.390371,"marketCap":2890916729},{"date":"2025-08-22","current":56.617249,"twenty":-35.016046,"median":-11.531835,"eighty":455.124507,"marketCap":3000714171},{"date":"2025-08-29","current":56.217043,"twenty":-34.774556,"median":-11.495509,"eighty":452.199783,"marketCap":2979503301},{"date":"2025-09-05","current":58.218069,"twenty":-34.549166,"median":-11.478929,"eighty":451.73199,"marketCap":3085557648},{"date":"2025-09-12","current":56.217043,"twenty":-34.412321,"median":-11.359567,"eighty":448.786711,"marketCap":2979503301},{"date":"2025-09-19","current":53.886437,"twenty":-33.856664,"median":-11.154173,"eighty":447.963884,"marketCap":2855981179},{"date":"2025-09-26","current":53.698106,"twenty":-33.722781,"median":-10.357169,"eighty":447.295534,"marketCap":2845999594},{"date":"2025-10-03","current":54.757472,"twenty":-33.367838,"median":-10.329434,"eighty":441.423222,"marketCap":2902146013},{"date":"2025-10-10","current":56.852663,"twenty":-32.522883,"median":-10.193594,"eighty":438.319895,"marketCap":3013191153},{"date":"2025-10-17","current":58.123903,"twenty":-32.191426,"median":-10.136885,"eighty":437.230259,"marketCap":3080566855},{"date":"2025-10-24","current":59.51285,"twenty":-31.936305,"median":-10.050254,"eighty":437.029825,"marketCap":3154181049},{"date":"2025-10-31","current":49.115471,"twenty":-31.768326,"median":-9.994441,"eighty":436.655789,"marketCap":3634544856},{"date":"2025-11-07","current":53.771536,"twenty":-31.614854,"median":-9.940515,"eighty":432.826301,"marketCap":3979093697},{"date":"2025-11-14","current":50.329618,"twenty":-31.467797,"median":-9.877834,"eighty":422.57095,"marketCap":3724391747},{"date":"2025-11-21","current":53.602815,"twenty":-31.224616,"median":-9.739044,"eighty":418.358561,"marketCap":3966608307},{"date":"2025-11-28","current":33.831379,"twenty":-31.10089,"median":-9.452398,"eighty":417.079998,"marketCap":4195090939},{"date":"2025-12-05","current":34.838265,"twenty":-31.035365,"median":-9.406482,"eighty":410.227055,"marketCap":4319944836},{"date":"2025-12-12","current":36.036459,"twenty":-30.949051,"median":-9.187795,"eighty":401.908655,"marketCap":4468520973},{"date":"2025-12-19","current":35.784738,"twenty":-30.882422,"median":-9.077235,"eighty":398.328327,"marketCap":4437307499},{"date":"2025-12-26","current":36.409007,"twenty":-30.838389,"median":-9.037302,"eighty":355.290696,"marketCap":4514716915},{"date":"2026-01-02","current":36.127079,"twenty":-30.768476,"median":-9.020236,"eighty":289.603812,"marketCap":4479757824},{"date":"2026-01-09","current":35.754531,"twenty":-30.593054,"median":-8.994538,"eighty":279.199129,"marketCap":4433561882},{"date":"2026-01-16","current":33.111455,"twenty":-30.162922,"median":-8.926675,"eighty":268.955119,"marketCap":4105820402},{"date":"2026-01-23","current":33.770965,"twenty":-29.887031,"median":-8.908086,"eighty":268.277658,"marketCap":4187599705},{"date":"2026-01-30","current":34.949022,"twenty":-29.648103,"median":-8.907363,"eighty":262.669758,"marketCap":4333678764},{"date":"2026-02-06","current":34.687232,"twenty":-28.870039,"median":-8.882251,"eighty":139.280173,"marketCap":4301216751},{"date":"2026-02-13","current":33.99248,"twenty":-28.353691,"median":-8.848243,"eighty":59.385726,"marketCap":4215067562},{"date":"2026-02-20","current":34.677163,"twenty":-28.238411,"median":-8.731325,"eighty":59.244477,"marketCap":4299968212},{"date":"2026-02-27","current":20.042023,"twenty":-28.144728,"median":-8.655829,"eighty":59.018479,"marketCap":4208824867},{"date":"2026-03-06","current":19.087338,"twenty":-28.07439,"median":-8.478095,"eighty":58.74069,"marketCap":4008341006},{"date":"2026-03-13","current":18.378635,"twenty":-27.9958,"median":-7.827701,"eighty":58.632399,"marketCap":3859513368},{"date":"2026-03-20","current":18.164238,"twenty":-27.926913,"median":-7.703119,"eighty":58.505275,"marketCap":3814489881},{"date":"2026-03-27","current":17.836686,"twenty":-27.874039,"median":-7.514349,"eighty":58.29811,"marketCap":3745703997},{"date":"2026-04-02","current":17.794815,"twenty":-27.836472,"median":-6.995266,"eighty":58.236902,"marketCap":3736911077},{"date":"2026-04-10","current":18.758579,"twenty":-27.751968,"median":-6.894174,"eighty":58.199236,"marketCap":3939301693},{"date":"2026-04-17","current":18.294115,"twenty":-27.679313,"median":16.982644,"eighty":58.114486,"marketCap":3841764047},{"date":"2026-04-24","current":19.252074,"twenty":-27.620734,"median":17.503178,"eighty":58.072112,"marketCap":4042935443},{"date":"2026-05-01","current":17.794815,"twenty":-27.559726,"median":17.69031,"eighty":58.025029,"marketCap":4484293293},{"date":"2026-05-08","current":19.159181,"twenty":-27.4491,"median":17.730951,"eighty":57.88378,"marketCap":4828113496},{"date":"2026-05-15","current":18.302823,"twenty":-27.391357,"median":17.815751,"eighty":57.742531,"marketCap":4612311454},{"date":"2026-05-22","current":18.123811,"twenty":-27.288803,"median":17.836686,"eighty":57.620115,"marketCap":4567200292},{"date":"2026-05-29","current":17.712566,"twenty":-27.245913,"median":17.896416,"eighty":57.582449,"marketCap":4463566543},{"date":"2026-06-05","current":18.118973,"twenty":-27.042075,"median":17.815751,"eighty":57.417659,"marketCap":4565981072},{"date":"2026-06-12","current":18.447969,"twenty":-26.689807,"median":17.954474,"eighty":57.347034,"marketCap":4648888071},{"date":"2026-06-18","current":18.351205,"twenty":-26.089973,"median":18.089943,"eighty":57.271701,"marketCap":4624503659},{"date":"2026-06-26","current":19.976832,"twenty":-25.921332,"median":18.140745,"eighty":57.196369,"marketCap":5034161774},{"date":"2026-07-02","current":19.473662,"twenty":-25.822694,"median":18.173171,"eighty":57.168119,"marketCap":4907362834},{"date":"2026-07-10","current":19.981671,"twenty":-25.687845,"median":18.198802,"eighty":56.975079,"marketCap":5035380995},{"date":"2026-07-17","current":19.63816,"twenty":-25.580272,"median":18.293631,"eighty":56.852663,"marketCap":4948816334},{"date":"2026-07-24","current":19.599455,"twenty":-25.493702,"median":18.346367,"eighty":56.796163,"marketCap":4939062569},{"date":"2026-07-31","current":19.459148,"twenty":-25.451449,"median":18.378635,"eighty":56.749081,"marketCap":4903705172},{"date":"2026-08-07","current":12.819067,"twenty":-25.369514,"median":18.324595,"eighty":56.725539,"marketCap":4563587806},{"date":"2026-08-14","current":12.669892,"twenty":-25.215019,"median":18.293147,"eighty":56.692581,"marketCap":4510481664},{"date":"2026-08-21","current":12.524033,"twenty":-25.098157,"median":18.192754,"eighty":56.645498,"marketCap":4458555659},{"date":"2026-08-28","current":11.701915,"twenty":-25.029903,"median":18.164238,"eighty":56.579583,"marketCap":4165881809},{"date":"2026-09-04","current":11.546111,"twenty":-24.99181,"median":18.121392,"eighty":56.438333,"marketCap":4110415394},{"date":"2026-09-11","current":11.440031,"twenty":-24.975865,"median":18.055625,"eighty":56.292376,"marketCap":4072651026},{"date":"2026-09-16","current":11.343896,"twenty":-24.967722,"median":17.954474,"eighty":56.235876,"marketCap":4038427068}],"updateTime":1789692254666},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INDV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656555341","title":"Indivior Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656555341","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656555341?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:01","pubTimestamp":1785844898,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryIndivior Pharmaceuticals IncINDV.OQreported quarterly adjusted earnings of $1.15 per share for the quarter ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4411DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656304910","title":"Switzerland's Crispr Therapeutics Q2 Casgevy Revenue Jumps 151%, Net Loss Narrows on FDA Approval for Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304910","media":"Reuters","labels":["productRelease","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304910?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:26","pubTimestamp":1785788805,"startTime":"0","endTime":"0","summary":"Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansionOverviewSwitzerland-U.S. gene-editing firm's Q2 CASGEVY revenue rose 151% yr/yr to $76 ml","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N440114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","TGTX","BK4588","BK4139","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656304555","title":"Crinetics Q2 Revenue Jumps on Palsonify Launch, Withdraws Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304555","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304555?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:22","pubTimestamp":1785788546,"startTime":"0","endTime":"0","summary":"Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidanceOverviewU.S. endocrine drugmaker's Q2 revenue rose sharply on PALSONIFY launchCompany's Q2 net loss widened, while loss per share narr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","BK4007","INDV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656930664","title":"Germany's Fresenius Medical Q2 Revenue Beats; 2026 Outlook Reaffirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2656930664","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656930664?lang=en_us&edition=fundamental","pubTime":"2026-08-04 02:33","pubTimestamp":1785782036,"startTime":"0","endTime":"0","summary":"Germany's Fresenius Medical Q2 revenue beats; 2026 outlook reaffirmedOverviewGermany dialysis provider's Q2 revenue rose 1% yr/yr, beating analyst expectationsQ2 operating income grew 10% yr/yr; net i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656308800","title":"U.S. Stocks on the MOVE -Visa, Bowhead Specialty, Micron","url":"https://stock-news.laohu8.com/highlight/detail?id=2656308800","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656308800?lang=en_us&edition=fundamental","pubTime":"2026-08-03 23:43","pubTimestamp":1785771804,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE -Visa, Bowhead Specialty, MicronAugust 3 (Reuters)-Wall Street's main indexes opened higher on the first trading day of August as signs of de-escalating tensions in the Mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL6N4400ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGN","ARES","ONLN","SES","COHR","LUV","COHC","JGRO","FANG","SUPN","TTXU","PLOW","BMY","SO","MPWR","FSLR","ELPW","ATKR","BOW","TSN","688825","UAL","FICO","PN","XOM","V","ITGR","HYFM","APA","CNH","GME","MAR","09988","AMC","GMEY","AZN.UK","LNTH","FDNI","GUNZ","MU","PCOR","BABA","IR","BFLY","AXON","INDV","AAL","DAL","CVX","COHX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656148371","title":"Indivior and Supernus announce tax-free merger of equals","url":"https://stock-news.laohu8.com/highlight/detail?id=2656148371","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656148371?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:01","pubTimestamp":1785762109,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Indivior ( ($INDV) ). Indivior Pharmaceuticals, Inc. is a biopharmaceutical company focused on central nervous ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-and-supernus-announce-tax-free-merger-of-equals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-and-supernus-announce-tax-free-merger-of-equals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656667375","title":"Supernus, Indivior Merge to Strengthen Neuroscience Drug Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2656667375","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656667375?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:28","pubTimestamp":1785756539,"startTime":"0","endTime":"0","summary":"Supernus, Indivior merge to strengthen neuroscience drug portfolioAug 3 (Reuters)-Supernus PharmaceuticalsSUPN.Oand Indivior PharmaceuticalsINDV.Osaid on Monday they had agreed to an all-stock merger ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4N4400WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV","SUPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373720","title":"TG Therapeutics Q2 Product Revenue Rises 70% on Briumvi Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373720","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373720?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:13","pubTimestamp":1785755580,"startTime":"0","endTime":"0","summary":"TG Therapeutics Q2 product revenue rises 70% on BRIUMVI salesOverviewU.S. biotech's Q2 product revenue rose 70% yr/yr, driven by BRIUMVI salesQ2 net income and EPS declined from prior year as expenses","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4588","MRNA","MRNY","TGTX","BK4501","BK4568","BK4585","BK4548","IDNA","BK4551","MRNX","BK4532","INDV","GNOM","BK4007","BK4534","LGHT","TENX","BK4139","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656437362","title":"Indivior Announces Merger Agreement to Acquire Supernus","url":"https://stock-news.laohu8.com/highlight/detail?id=2656437362","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656437362?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:58","pubTimestamp":1785754722,"startTime":"0","endTime":"0","summary":"Indivior ( ($INDV) ) just unveiled an announcement. On August 1, 2026, Indivior and Artemis Merger Sub entered into a merger agreement with Supernu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-announces-merger-agreement-to-acquire-supernus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-announces-merger-agreement-to-acquire-supernus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656015378","title":"Indivior Pharmaceuticals, Supernus Pharmaceuticals to Combine in All-Stock Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2656015378","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656015378?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:52","pubTimestamp":1785754357,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals, Supernus Pharmaceuticals to Combine in All-Stock Merger","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","INDV","SUPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378109","title":"Indivior Pharmaceuticals Inc: Supernus Must Pay Co Termination Fee of $101 Mln if the Merger Agreement is Terminated Under Certain Circumstances","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656378109?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:42","pubTimestamp":1785753772,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN43Y02R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378122","title":"Indivior Pharmaceuticals Beats Q2 Revenue on Sublocade Growth, Raises FY Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378122","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656378122?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:41","pubTimestamp":1785753692,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals beats Q2 revenue on Sublocade growth, raises FY guidanceOverviewU.S. opioid treatment maker's Q2 revenue rose 14%, beating analyst expectationsAdjusted EPS for Q2 beat consens","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","LU1244550221.USD","IE0000B7K699.USD","BK4551","BK4581","IE00BJJMRZ35.SGD","LU0553294199.USD","PPH","XLV","IXJ","LU2237443978.SGD","FTXH","LGHT","LU2125909593.SGD","IE0004445239.USD","ABBV","GLAM","IE00BVYPNW00.USD","RXL","BK4566","FHLC","WDNA","LU0868494617.USD","VHT","JDOC","TRUH","LU2237443465.HKD","MEDX","BK4139","LU0545039389.USD","IE000WAW04H5.SGD","LU0738911758.USD","LU2237443895.HKD","LU0069063385.USD","IDNA","MRNX","LU1023059063.AUD","LU0203347892.USD","LU0211327993.USD","GNOM","LU2237443382.USD","LU0310800379.SGD","MRNY","PJP","AGNG","BK4533","IYH","LU1989771016.USD","LU0158827948.USD","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378999","title":"GUIDANCE: (INDV) Indivior Expects 2026 Net Revenue Range $1.30B - $1.37B, vs. FactSet Est of $1.26B","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378999","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656378999?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:37","pubTimestamp":1785753461,"startTime":"0","endTime":"0","summary":"GUIDANCE: (INDV) Indivior Expects 2026 Net Revenue Range $1.30B - $1.37B, vs. FactSet Est of $1.26B","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656337862","title":"Supernus Q2 FY26 Net Loss Widens to $58.4 Million; Revenue Rises 32% to $219.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656337862","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656337862?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:35","pubTimestamp":1785753338,"startTime":"0","endTime":"0","summary":"Supernus Q2 FY26 net loss widens to $58.4 million; revenue rises 32% to $219.1 millionSupernus posted Q2 2026 revenue of USD 219.1 million, up 32% from a year earlier.GAAP results swung to a net loss ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL4qXB6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BCDF","INDV","BK4007","NDAQ","SG9999014005.SGD","SUPN","BK4112","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656617378","title":"Indivior Q2 Adj. EPS $1.15 Beats $0.87 Estimate, Sales $343.000M Beat $307.550M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656617378","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656617378?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:35","pubTimestamp":1785753313,"startTime":"0","endTime":"0","summary":"Indivior Q2 Adj. EPS $1.15 Beats $0.87 Estimate, Sales $343.000M Beat $307.550M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/INDV","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656786183","title":"Supernus Pharmaceuticals Shares Rise 5.3% Premarket After Co to Merge with Indivior Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2656786183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656786183?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:35","pubTimestamp":1785753304,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4N4400UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SUPN","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378541","title":"Indivior Q2 FY26 GAAP Net Income Rises to $122 Million; Revenue Increases 14% to $343 Million YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378541","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656378541?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:32","pubTimestamp":1785753155,"startTime":"0","endTime":"0","summary":"Indivior Q2 FY26 GAAP net income rises to $122 million; revenue increases 14% to $343 million YoYIndivior posted Q2 2026 net revenue of $ 343 million, up 14% year-over-year; GAAP net income climbed to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9BZXlY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2W23.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","SG9999014039.USD","SG9999014021.USD","INDV","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4588","SG9999014005.SGD","BK4585","IE00BN0W2T93.GBP","BK4007","NDAQ","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378542","title":"Indivior Pharmaceuticals Q2 Revenue USD 343 Million Vs. IBES Estimate USD 307.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378542","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656378542?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:32","pubTimestamp":1785753121,"startTime":"0","endTime":"0","summary":"BRIEF-Indivior Pharmaceuticals Q2 Revenue USD 343 Million Vs. IBES Estimate USD 307.6 MillionAug 03 (Reuters) - Indivior Pharmaceuticals Q2 net income USD 122 million.Outlook FY revenue USD 1,295-1,365 millionOutlook FY adjusted EBIT USD 700-740 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLXV41X96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656537853","title":"Indivior Pharmaceuticals Outlook FY Revenue USD 1,295-1,365 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656537853","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656537853?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:31","pubTimestamp":1785753061,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLXV41X96:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378596","title":"Press Release: Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378596","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656378596?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:31","pubTimestamp":1785753060,"startTime":"0","endTime":"0","summary":"-- Grew total SUBLOCADE net revenue 21% year-over-year to $253 million. U.S.SUBLOCADE net revenue increased 22% year-over-year to $238 million versus. the prior year, driven by 18% dispense unit volume growth. New patient. starts of 32,816 were a record. Net revenue also benefited from more. -- In the second quarter, Indivior repurchased 4,664,540 shares at an. average price of $37.52 for a total of $175 million. Year-to-date, the. Company has repurchased 8,638,693 shares at an average price of $34.73. -- Announced findings from two new real-world evidence studies showing that. adherence to SUBLOCADE is associated with lower relapse risk, fewer. -- Indivior Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. today. announced a definitive agreement to combine in an all-stock merger of. equals transaction to create a leading, diversified, scaled, CNS-focused","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","LU0368265764.SGD","LU0612318971.USD","LU0612318385.USD","LU0654597011.USD","SG9999002521.SGD","LU0330918003.SGD","LU0630314457.HKD","LU0345780950.USD","LU0498741890.SGD","BU","LU0498741114.HKD","LU0345781412.USD","LU0055631609.USD","LU1023059493.AUD","PMDE","BK4017","B","BK4007","LU0788108826.HKD","LU1430597077.USD","GXDW","VGFPF","JOYT","LU0300736062.USD","LU0345780281.USD","R","BK4232","FEBU","LU0345780521.USD","LU0724618789.USD","SG9999001143.SGD","LU0496367417.USD","DECU","BK4161","VOTE","LU0788109121.HKD","LU0300736492.USD","RGLO","LU0075056555.USD","INDV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":98,"code":"91000000","status":"200"}]}}